108787 ⎘
Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor; Animal cells or tissues; Human cells or tissues; Vertebrate cells; Cells of skeletal and connective tissues; Mesenchyme Cardiomyocytes; Heart cells
METHODS AND PRODUCTS FOR TRANSFECTION
#2CELL CULTURE SUBSTRATE EQUIPPED WITH LAYERED MYOCARDIAL CELL SHEET AND METHOD FOR MANUFACTURING SAME, AND METHOD FOR EVALUATING NORMAL MYOCARDIAL CELL SHEET FOR TRANSPLANTATION
#3MINIMAL ESSENTIAL MEDIA FOR THE CULTURE OF HUMAN INDUCED PLURIPOTENT STEM CELLS
#4METHODS AND PRODUCTS FOR TRANSFECTING CELLS
#5CLINICAL DERIVATIONS OF AN ALLOGENIC CELL AND THERAPEUTIC USES
#6Cell Tissue Production Method, Application Method and Application Device
#7MAKING AND USING CARDIOPOIETIC CELLS
#8CARDIAC FIBROBLAST DERIVED EXTRACELLULAR MATRIX
#9METHODS AND PRODUCTS FOR TRANSFECTING CELLS
#10METHOD FOR PRODUCING CARDIAC MUSCLES
#11ATRIOVENTRICULAR NODE-LIKE PACEMAKER CELLS
#12NON-IMMUNOGENIC ENGINEERED TISSUE AND METHODS OF PRODUCING AND USING THE SAME
#13CULTURED CELL SHEET AND METHOD FOR PRODUCING SAME; METHOD FOR EVALUATING COMPOUND OR DRUG; AND METHOD FOR EVALUATING QUALITY OF CULTURED CELL SHEET
#14SMALL MOLECULES AND METHODS FOR INDUCING CARDIOMYOCYTE PROLIFERATION
#15MICRORNAS FOR CARDIAC REGENERATION THROUGH INDUCTION OF CARDIAC MYOCYTE PROLIFERATION
#16METHODS AND COMPOSITIONS FOR THE CLINICAL DERIVATION OF A STEM CELL AND THERAPEUTIC USES
#17CELL THERAPY COMPOSITIONS AND METHODS OF MANUFACTURE
#18MESENCHYMAL STEM CELL-DERIVED EXTRACELLULAR VESICLE COMPOSITIONS AND USES THEREOF
#19METHODS AND COMPOSITIONS FOR MATURING CARDIOMYOCYTES
#20CARDIOPROTECTIVE HEART DISEASE THERAPIES
#21SODIUM SALT AND ETHANOLAMINE SALT OF 23-HYDROXYTORMENTIC ACID
#22HEART TISSUE MODEL
#23CARDIOMYOCYTE SUBTYPES AND METHODS OF MAKING AND USING
#24METHODS AND PRODUCTS FOR TRANSFECTION
#25MULTIPLE HEART TISSUE CULTURE FUSION
#26CARDIOMYOCYTES AND COMPOSITIONS AND METHODS FOR PRODUCING THE SAME
#27EPICARDIAL CELL REGENERATION PROMOTER AND METHOD FOR PROMOTING EPICARDIAL CELL REGENERATION
#28GENETICALLY MODIFIED CELLS FOR ENHANCED IMMUNE EVASION IN ALLOGENEIC CELLULAR THERAPIES
#29CELLS DIFFERENTIATED FROM IMMUNOENGINEERED PLURIPOTENT CELLS
#30ACTIVATION-INDUCED TISSUE-EFFECTOR CELLS SUITABLE FOR CELL THERAPY AND EXTRACELLUAR VESICLES DERIVED THEREFROM
#31GENETICALLY MODIFIED CELLS FOR ENHANCED IMMUNE EVASION IN ALLOGENEIC CELLULAR THERAPIES
#32METHOD TO IMPROVE CELL VIABILITY OF CARDIOMYOCYTES
#33METHOD OF FORMING AN ALIGNED TISSUE OR TISSUE CONSTRUCT, A TISSUE OR TISSUE CONSTRUCT, AND BIOINK
#34COMPOSITIONS AND METHODS FOR DETECTING CARDIOTOXICITY
#35CARDIOPULMONARY PROGENITOR EXOSOMES, PREPARATION METHOD AND APPLICATION THEREOF
#36IMMUNE MODULATORY PARACRINE ACTING CELLS (IMPACS)
#37CARDIOMYOCYTES AND COMPOSITIONS AND METHODS FOR PRODUCING THE SAME
#38Promotion of Cardiomyocyte Proliferation and Regenerative Treatment of the Heart by Inhibition of microRNA-128
#39A COMBINED HUMAN GASTRULOID MODEL OF CARDIOGENESIS AND NEUROGENESIS
#40Cell Therapy
#41CELL-SPECIFIC EXPRESSION OF modRNA
#42GENERATION OF DEOXYADENOSINE TRIPHOSPHATE DONOR CELLS AND USES THEREOF
#43METHODS FOR IN VITRO EVALUATION USING FUNCTIONAL ENGINEERED THREE-DIMENSIONAL TISSUES WITH CIRCUMFERENTIAL OR HELICALLY ORIENTED TISSUE STRUCTURE
#44PHYSIOLOGICAL BIOMIMETIC CULTURE SYSTEM FOR HEART SLICES
#45METHODS TO ACCELERATE STEM CELL DIFFERENTIATION TO CARDIOMYOCYTES
#46METHODS AND COMPOSITIONS FOR CARDIAC MODELS
#47GENETICALLY MODIFIED CELLS AND COMPOSITIONS AND USES THEREOF
#48METHOD FOR EVALUATING CARDIOMYOCYTES USING RAMAN SCATTERING
#49METHOD OF MANUFACTURING AUTOLOGOUS CARDIAC LINEAGE CELLS
#50COMPOSITIONS AND METHODS FOR ENHANCING CARDIOMYOCYTE TRANSPLANT ENGRAFTMENT
#51METHODS FOR OBTAINING CARDIOMYOGENIC PRECURSOR CELLS
#52DOMINANT ACTIVE YAP, A HIPPO EFFECTOR, INDUCES CHROMATIN ACCESSIBILITY AND CARDIOMYOCYTE RENEWAL
#53CULTURE MEDIUM COMPOSITION FOR MATURATING CARDIOMYOCYTES DERIVED FROM PLURIPOTENT MAMMALIAN STEM CELLS
#54CARDIOVASCULAR CELL CO-CULTURE MEDIUM AND METHOD OF GROWING MULTIPLE CARDIOVASCULAR CELL TYPES
#55CARDIAC ORGANOID WITH INNER PART HAVING CAVITIES AND MULTIPLE LAYERS
#56METHOD FOR EVALUATING CELL DIFFERENTIATION STATE, METHOD FOR DETERMINING CELL DIFFERENTIATION STATE, AND METHOD FOR PRODUCING CARDIOMYOCYTES
#57Use of Long Non-Coding RNA (lncRNA) in Preparation of Drug for Controlling Myocardial Infarction
#58METHODS FOR PREPARING ENGINEERED MICROVESSELS AND APPLICATIONS THEREOF
#59CONSTRUCTION METHOD, DETECTION METHOD, AND APPLICATION OF IN VITRO TISSUE MODEL OF DIABETIC CARDIOMYOPATHY
#60CELL OBTAINING METHOD FOR CREATING NFT BASED ON CELL IMAGE
#61HUMAN INDUCED PLURIPOTENT STEM CELLS-DIFFERENTIATED CARDIOMYOCYTES, METHODS OF PRODUCING THE SAME, AND USES THEREOF IN TREATING CARDIAC DISEASES
#62MATURATION MEDIUM FOR PLURIPOTENT STEM CELL-DERIVED CARDIOMYOCYTES
#63COMPOSITIONS OF HUMAN HEART DERIVED EXTRACELLULAR VESICLES AND USES THEREOF
#64METHOD FOR PRODUCING PLURIPOTENT STEM CELLS
#65UNIVERSAL STEM CELL AND USES THEREOF
#66MEMBRANE BOUND COMPOSITIONS AND METHODS RELATING TO SAME
#67MAMMALIAN CARDIAC REGENERATION
#68GENERATING ATRIAL AND VENTRICULAR CARDIOMYOCYTE LINEAGES FROM HUMAN PLURIPOTENT STEM CELLS
#69Method of Processing Collagen-based Tissue for Bioprosthetic Devices
#70GENERATING CARDIAC PROGENITOR CELLS FROM PLURIPOTENT STEM CELLS USING ISOXAZOLE OR ISOXAZOLE LIKE COMPOUNDS
#71Method for Producing Cardiomyocytes by Means of Reprogramming
#72PRE-EPICARDIAL CELLS AND USES THEREOF
#73Electrospun PNIPAAm/PCL Fiber Mats for Aligned Cell Sheets
#74DIRECT REPROGRAMMING OF CELLS INTO CARDIAC PURKINJE-LIKE CELLS USING A UNIVERSAL SMALLMOLECULE COCKTAIL
#75CARDIOSPHERE-DERIVED CELLS AND THEIR EXTRACELLULAR VESICLES FOR TREATMENT AND PREVENTION OF CANCER
#76Methods for producing cardiomyocyte cells
#77CARDIOMYOCYTE PRODUCTION METHOD
#78METHODS OF INDUCING CARDIAC CELL PROLIFERATION AND INDUCING HEART REGENERATION
#79ASSAY FOR SARS-CoV-2 INFECTION OF VULNERABLE HUMAN CELLS
#80PRODUCTION METHOD OF MYOCARDIAL CELL LAYER, MYOCARDIAL CELL LAYER, AND USE THEREOF
#81METHODS AND COMPOSITIONS FOR CELL REPROGRAMMING
#82EFFICIENT DIFFERENTIATION OF SECOND HEART FIELD CARDIAC PROGENITOR CELLS AND RIGHT VENTRICLE CARDIOMYOCYTES FROM HUMAN PLURIPOTENT STEM CELLS
#83CARDIAC ORGANOID AND ANTI-ELECTRO-MITOCHONDRIAL DESYNCHRONIZATION THERAPY
#84MICRORNAS FOR CARDIAC REGENERATION THROUGH INDUCTION OF CARDIAC MYOCYTE PROLIFERATION
#85SPONTANEOUSLY BEATING CARDIAC ORGANOID CONSTRUCTS AND INTEGRATED BODY-ON-CHIP APPARATUS CONTAINING THE SAME
#86METHOD FOR INDUCED DIFFERENTIATION OF EXTENDED PLURIPOTENT STEM CELL INTO CARDIOMYOCYTE AND USE THEREOF
#87VASCULARIZED CARDIAC ORGANOID WITH A CHAMBER STRUCTURE AND ITS PREPARATION METHOD
#88ELECTROPHYSIOLOGICAL MODIFICATION TO SUPPRESS ARRHYTHMIAS
#89METHOD FOR PRODUCING VASCULARIZED BIOLOGICAL TISSUE
#90CELL AND COLLAGEN COMPOSITIONS FOR ENGINEERED CARDIAC TISSUE
#91CELL TISSUE PRODUCTION METHOD, CELL TISSUE PRODUCTION SET, AND CULTIVATION CONTAINER CONTAINING CELL TISSUE PRODUCED BY SAID PRODUCTION METHOD
#92MULTI-ORGAN MODEL
#93METHODS FOR THE PRODUCTION OF CARDIAC FIBROBLASTS
#94METHOD FOR INDUCED DIFFERENTIATION OF EXTENDED PLURIPOTENT STEM CELL INTO CARDIOMYOCYTE AND USE THEREOF
#95Vascularized cardiac organoid with a chamber structure and its preparation method
#963D BIOPHOTONIC DEVICES FOR OPTICAL ELECTROPHYSIOLOGY AND METHODS OF USE THEREOF
#97CARDIOGENIC MESODERM FORMATION REGULATORS
#98A DUAL CARDIAC-BLOOD MODEL SYSTEM FOR DISEASE MODELLING AND DRUG SCREENING
#99STEM CELL-DERIVED MATURE CARDIOMYOCYTES AND CARDIOVASCULAR DISEASE MODEL USING SAME
#100BONE MARROW DERIVED NEUROKININ-1 RECEPTOR POSITIVE (NK1R+) MESENCHYMAL STEM CELLS FOR THERAPEUTIC APPLICATIONS
#101Methods and Compositions for Diagnosing and Treating Rare Genetic DIseases
#102METHODS AND SYSTEMS FOR FUNCTIONAL MATURATION OF iPSC AND ESC DERIVED CARDIOMYOCYTES
#103CELLS WITH SUSTAINED TRANSGENE EXPRESSION
#104PREPARATION METHOD OF MOFs-COATED CARDIOMYOCYTE CORE-SHELL STRUCTURE
#105MID-SCALE VESSELS IN ENGINEERED TISSUE FOR REGENERATION
#106METHOD OF INDUCING CARDIOMYOCYTES PROLIFERATION AND TREATING HEART DISEASES
#107A METHOD OF PRODUCING A CARDIOMYOCYTE SPHEROID
#108THREE-DIMENSIONAL CULTURE SYSTEM FOR GENERATING CARDIAC SPHEROIDS
#109Ultrathin Interfacial Layer on a Hydrogel to Direct its Surface Properties and Cell Adhesion
#110SELF-ORGANISED HUMAN CARDIAC ORGANOID
#111OPTOGENETIC MODULATION OF ACTION-POTENTIAL PROPERTIES
#112SOLUBILIZATION OF ANTIGEN COMPONENTS FOR REMOVAL FROM TISSUES
#113DIRECT CONVERSION OF HUMAN MESENCHYMAL STEM CELLS TO HUMAN CARDIOMYOCYTES
#114PARTICULAR CARDIAC TISSUE AND ITS USE IN THE TREATMENT OF CARDIAC PATHOLOGIES
#115SPHEROIDAL SELF-ASSEMBLED PEPTIDE HYDROGELS COMPRISING CELLS
#116GENETIC MARKERS FOR ENGRAFTMENT OF HUMAN CARDIAC VENTRICULAR PROGENITOR CELLS
#117Methods for Cardiac Differentiation of Human Induced Pluripotent Stem Cells
#118Development and characterization of f-gelatin electrospun scaffolds for cardiac tissue modeling
#119CELLULAR MICROCOMPARTMENTS COMPRISING HUMAN CELLS UNDERGOING CARDIAC DIFFERENTIATION, TISSUES OBTAINED FROM THESE MICROCOMPARTMENTS AND USES
#120CELL MEDIUM FORMULATION FOR CELL STABILIZATION
#121DECELLULARIZED MAMMALIAN EXTRACELLULAR MATRIX MORSELS, METHODS MAKING AND METHODS OF USING SAME
#122COMPOSITIONS AND METHODS FOR PROMOTING PROLIFERATION IN CARDIOMYOCYTES
#123HYDROGEL ASSISTED STEREOLITHOGRAPHIC ELASTOMER PROTOTYPING
#124NANO-PATTEREND CONDUCTIVE POLYMER SUBSTRATE WITH IMPROVED CELL ALIGNMENT, MATURITY, ADHESION, AND CONNECTIVITY AND METHOD FOR MANUFACTURING SAME
#125ACTIVATED PLURIPOTENT STEM CELL, AND PREPARATION METHOD THEREFOR AND USE THEREOF
#126METHODS AND PRODUCTS FOR TRANSFECTING CELLS
#127HEART TISSUE MODEL
#128METHODS AND ASSAYS FOR ANALYZING SECRETOME-CONTAINING COMPOSITIONS
#129METHODS AND PRODUCTS FOR TRANSFECTING CELLS
#130HYBRID ALLOSTERIC RECEPTOR-ENGINEERED STEM CELLS
#131Devices and Methods to Induce Adult type Maturation of Human Pluripotent Stem Cell Derived Cardiomyocytes
#132METHODS FOR EVALUATING CARDIAC SAFETY OF DRUG USING CARDIOMYOCYTES DERIVED FROM HUMAN STEM CELLS
#133METHOD FOR PRODUCING HUMAN PLURIPOTENT STEM CELL-DERIVED CARDIAC ORGANOIDS AND HUMAN PLURIPOTENT STEM CELL-DERIVED CARDIAC ORGANOIDS PRODUCED THEREBY
#134METHODS OF INCREASING MATURATION OF HEART, PANCREATIC BETA-CELLS, AND NEURONS
#135METHOD FOR PRODUCING CARDIOMYOCYTE SPHEROIDS
#136COMPOSITIONS AND METHODS FOR CARDIAC TISSUE REPAIR
#137MASS PRODUCTION OF HUMAN PLURIPOTENT STEM CELL DERIVED CARDIAC STROMAL CELL
#138USE OF FATE MODULATORS TO IMPROVE NERVE REGENERATION
#139METHODS AND COMPOSITIONS FOR MAKING AND USING ENDOCARDIAL CELLS
#140Support and System for Engineered Tissue
#141C-KIT-POSITIVE BONE MARROW CELLS AND USES THEREOF
#142PRE-TREATING CARDIOMYOCYTES WITH ANTI-ARRHYTHMIC DRUGS TO REDUCE ENGRAFTMENT ARRHYTHMIA
#143METHODS AND PRODUCTS FOR TRANSFECTING CELLS
#144MicroRNA-TARGETED THERAPY FOR CARDIAC REPAIR
#145METHOD OF PRODUCING CARDIOMYOCYTE POPULATION, METHOD OF PROLIFERATING CARDIOMYOCYTES, CARDIOMYOCYTE POPULATION, TRANSPLANTATION MATERIAL, MULTINUCLEATED CARDIOMYOCYTE, AND KIT FOR PROLIFERATING CARDIOMYOCYTES
#146RECOMBINANT CARDIOMYOCYTES AND CARDIOMYOCYTE CELL LINES EXPRESSING HERG
#147METHODS FOR REPROGRAMMING CELLS AND USES THEREOF
#148GENE-THERAPY VECTORS FOR TREATING CARDIOMYOPATHY
#149METHOD FOR DIRECT TRANSDIFFERENTIATION OF SOMATIC CELL
#150Carbon nanotube-functionalized reverse thermal gel and methods of forming and using same
#151PLURIPOTENT STEM CELL-DERIVED HEART ORGANOID
#152CARDIAC ORGANOID, MANUFACTURING METHOD THEREFOR, AND METHOD FOR EVALUATING DRUG TOXICITY BY USING SAME
#153METHOD FOR PURIFYING CARDIOMYOCYTES
#154Methods of Producing Specialized Cardio-Like Cells from Stem Cells
#155CARDIAC CELL PROLIFERATION BY ADMINISTERING INHIBITORS OF SAV1, NF2, MOB1 AND/OR MUTANT SRF
#156KLF Induced Cardiomyogenesis
#157COMPOSITION FOR CRYOPRESERVATION OF MYOCARDIAL CELLS
#158ORGAN INFECTION MODELS
#159NOVEL FABRICATION OF CORONARY BASED DECELLULARIZED HEART FLAPS TO TREAT ANEURYSM FOLLOWING MYOCARDIAL INFARCTION
#160USE OF CD34 AS A MARKER FOR SINOATRIAL NODE-LIKE PACEMAKER CELLS
#161ASSAY FOR DRUG DISCOVERY BASED ON IN VITRO DIFFERENTIATED CELLS
#162MULTI-LINEAGE CARDIOVASCULAR MICROFLUIDIC ORGAN-CHIP
#163BIOMIMETIC HEART TISSUE CULTURE SYSTEM
#164SAFE HARBOR LOCI
#165Methods and products for transfection
#166METHOD FOR PRODCING CARDIOMYOCYTES FROM INDUCED PLURIPOTENT STEM CELLS IN AN INTEGRATED PROCESS
#167CARDIAC CELL REPROGRAMMING WITH MICRORNAS AND OTHER FACTORS
#168MICROFLUIDIC DEVICE FOR A 3D TISSUE STRUCTURE
#169CARDIOMYOCYTE PURIFICATION METHOD
#170SYSTEMS AND METHODS FOR CARDIOMYOCYTE PACING
#171HEART EXTRACELLULAR MATRIX-DERIVED SCAFFOLD FOR CULTURE AND TRANSPLANTATION OF CARDIAC ORGANOID AND METHOD OF PREPARING THE SAME
#172DEVICE AND METHODS FOR ENGINEERING 3D COMPLEX TISSUES
#173METHODS OF TREATING AND PREVENTING ENGRAFTMENT ARRHYTHMIAS
#174CARDIAC FIBROBLAST DERIVED EXTRACELLULAR MATRIX
#175Use of MYOG gene as target in preparation of drug for treating cardiomyocyte apoptosis-associated cardiovascular disease
#176Dominant active yap, a hippo effector, induces chromatin accessibility and cardiomyocyte renewal
#177INDUCTION OF NEUROGENESIS USING UMBILICAL CORD DERIVED MESENCHYMAL STEM CELLS AND DERIVATIVES THEREOF
#178PROCESS FOR PRODUCING CARDIOMYOCYTES
#179Lineage Reprogramming to Induced Cardiac Progenitor Cells (iCPC) By Defined Factors
#180CULTURE AND DIFFERENTIATION OF PLURIPOTENT STEM CELLS
#181Methods and products for transfecting cells
#182Novel Heterocyclic Derivatives with Cardiomyocyte Proliferation Activity for Treatment of Heart Diseases
#183Adaptive electrode arrangement and method for implementation in a cell incubator system and applications thereof
#184METHODS FOR PRODUCING OR ISOLATING EPICARDIAL CELLS AND USES THEREOF
#185COMPOSITIONS AND METHODS FOR GENERATION OF SINOATRIAL NODE-LIKE CELLS AND THEIR USE IN DRUG DISCOVERY
#186Methods for Generating Cardiac Fibroblasts
#187ENCAPSULATION AND CARDIAC DIFFERENTIATION OF hiPSCs IN 3D PEG-FIBRINOGEN HYDROGELS
#188ENGINEERING SPATIAL-ORGANIZED CARDIAC ORGANOIDS FOR DEVELOPMENTAL TOXICITY TESTING
#189IMMORTALIZED CARDIAC STEM CELLS FOR CARDIAC REPAIR
#190Promotion of Cardiomyocyte Proliferation and Regenerative Treatment of the Heart by Inhibition of microRNA-128
#191METHODS AND COMPOSITIONS FOR GENERATING PACEMAKER CELLS
#192MICROENCAPSULATION-BASED ISOLATION OF HUMAN PLURIPOTENT AND MULTIPOTENT STEM CELLS AND METHODS OF MAKING AND USING THE SAME
#193DECELLULARIZATION METHOD
#194p63 inactivation for the treatment of heart failure
#195GENERATION OF QUIESCENT CARDIAC FIBROBLASTS FROM HUMAN INDUCED PLURIPOTENT STEM CELLS FOR IN VITRO MODELING OF CARDIAC FIBROSIS
#196Method for Inducing Pluripotent Stem Cells to Differentiate into Ventricular Cardiomyocytes In Vitro
#197COMPOSITIONS INCLUDING MOLECULES OF MODIFIED MRNA AND METHODS OF USING THE SAME
#198AUXOTROPHIC SELECTION METHODS
#199NOVEL MOLECULAR TOOLS TO VISUALIZE AND TARGET THE CARDIAC CONDUCTION SYSTEM (CCS)
#200ENGINEERED ADULT-LIKE HUMAN HEART TISSUE
#201THERAPY FOR HEART DISORDERS
#202CELLULAR SEEDING AND CO-CULTURE OF A THREE DIMENSIONAL FIBROBLAST CONSTRUCT
#203METHOD FOR ENRICHING CARDIAC MYOCYTES
#204METHOD FOR GENERATING CARDIAC TISSUE MIMETICS
#205MEMBRANE AND METHOD FOR CULTURE AND DIFFERENTIATION OF CELLS
#206ATRIAL CARDIAC MICROTISSUES FOR CHAMBER-SPECIFIC ARRHYTHMOGENIC TOXICITY RESPONSES
#207STEM CELL LINE FOR TREATMENT OF VARIOUS MEDICAL CONDITIONS
#208APPLICATION OF ANTIARRHYTHMIC AGENTS TO STEM CELL DERIVED CARDIOMYOCYTES AND USES THEREOF
#2093-D HUMAN MODEL OF COMPLEX CARDIAC ARRHYTHMIAS
#210METHODS AND COMPOSITIONS FOR THE CLINICAL DERIVATION OF A STEM CELL AND THERAPEUTIC USES
#211METHODS AND COMPOSITIONS FOR THE CLINICAL DERIVATION OF A STEM CELL AND THERAPEUTIC USES
#212METHODS AND COMPOSITIONS FOR THE CLINICAL DERIVATION OF A STEM CELL AND THERAPEUTIC USES
#213VECTORS AND METHODS FOR REGENERATIVE THERAPY
#214SORTING METHOD FOR PLURIPOTENT STEM CELL, PREDICTION METHOD FOR DIFFERENTIATION INDUCTION RESULT, AND PRODUCTION METHOD FOR CELL PRODUCT
#215METHODS AND COMPOSITIONS FOR TREATING CARDIOMYOCYTES
#216MICRORNAS FOR CARDIAC REGENERATION THROUGH INDUCTION OF CARDIAC MYOCYTE PROLIFERATION
#217Cardiomyocyte Compositions and Use Thereof
#218Cell-specific expression of modRNA
#219Artificial transcription factors and uses thereof
#220THERAPEUTICALLY ACTIVE CELLS AND EXOSOMES
#221Force Stimulation Loading Device and Working Method Thereof
#222GRID OF RESPONSES INDICATING DRUG SENSITIVITY
#223Additive Manufacturing of Functional Myocardial Tissue
#224CARDIOMYOCYTE PROLIFERATION
#225Genome-edited induced pluripotent stem cells, and cells derived therefrom, and uses thereof
#226Multicistronic miRNA delivery for cardiac reprogramming
#227METHOD FOR PRODUCING CARDIOMYOCYTE
#228HUMAN CARDIOMYOCYTE SEPARATION REAGENT, CULTURE MEDIUM, SEPARATION METHOD, AND CULTURE METHOD
#229MYOCARDIAL ORGANOIDS AND METHODS OF MAKING AND USES THEREOF
#230IMPROVED SURVIVAL OF HUMAN CELLS DIFFERENTIATED IN VITRO BY PRPF31 GENE EXPRESSION KNOCKDOWN
#231METHODS OF PROMOTING CELLULAR MATURATION WITH AMPK ACTIVATORS
#232METHOD FOR TRANSFECTION INTO CARDIOMYOCYTES USING CATIONIC LIPID
#233LARGE SCALE CELL MANUFACTURE SYSTEM
#234SORTING CELL-TYPE SPECIFIC EXTRACELLULAR VESICLES
#235EXOSOMES AND MICRO-RIBONUCLEIC ACIDS FOR TISSUE REGENERATION
#236METHODS FOR THE MATURATION OF CARDIOMYOCYTES ON AMNIOTIC FLUID CELL-DERIVED ECM, CELLULAR CONSTRUCTS, AND USES FOR CARDIOTOXICITY AND PROARRHYTHMIC SCREENING OF DRUG COMPOUNDS
#237FABRICATION TECHNIQUE FOR CARDIOMYOCYTE CLUSTER WITH IMPROVED VIABILITY IN CRYOPRESERVATION AND HYPOXIC CONDITION
#238USE OF NEUROPILIN-1 (NRP1) AS A CELL SURFACE MARKER FOR ISOLATING HUMAN CARDIAC VENTRICULAR PROGENITOR CELLS
#239Material and method for storing, transferring and delivering mesenchymal stem cells which are immediately available and functional in the context of a myocardial infarction
#240COMPOSITIONS AND METHODS FOR GENERATION OF HEART FIELD-SPECIFIC PROGENITOR CELLS
#241Physiological biomimetic culture system for heart slices
#242BLOOD TYPE O Rh- HYPO-IMMUNOGENIC PLURIPOTENT CELLS
#243Methods and Compositions for the Clinical Derivation of an Allogenic Cell and Therapeutic Uses
#244BIOINK FOR 3D DEPOSITION
#245IN VITRO METHOD OF DIFFERENTIATING A HUMAN PLURIPOTENT STEM CELL POPULATION INTO A CARDIOMYOCYTE CELL POPULATION
#246APPARATUS FOR TESTING A CARDIAC CATHETER UTILIZING LIVE CARDIAC CELLS
#247KITS AND METHODS FOR PERFORMING OPTICAL DYNAMIC CLAMP ON EXCITABLE CELLS
#248Engineering Of Innervated Tissue And Modulation Of Peripheral Organ Activity
#249Methods of Preserving Cells for Space Exploration and Compositions Related Thereto
#250Methods and Systems for In Vitro Cardiac Disease Modeling
#251Cardiosphere-derived cells and exosomes secreted by such cells in the treatment of heart failure with preserved ejection fraction
#252CARRIER FOR CELL CULTURE COMPRISING MICROCAPSULES CONTAINING NATURAL OIL
#253DIFFERENTIATION-INDUCED CELL POPULATION FROM WHICH UNDIFFERENTIATED CELLS HAVE BEEN REMOVED, USE OF SAME, AND METHOD FOR PRODUCING SAME
#254MICROCAPSULES CONTAINING NATURAL OIL AND PREPARATION METHOD THEREFOR
#255METHODS FOR TISSUE GENERATION
#256Videomicroscopy of contractile cell cultures and cell culture methods using same.
#257METHODS FOR PRODUCING CARDIOMYOCYTE CELLS
#258Electrospun PNIPAAm/PCL fiber mats for aligned cell sheets
#259Methods for Cardiac Fibroblast Differentiation of Human Pluripotent Stem Cells
#260CARDIOMYOCYTE PROLIFERATION PROMOTING AGENT AND USE THEREOF
#261METHOD FOR PRODUCING CELL SHEET, CARDIOMYOCYTE SHEET, AND KIT FOR PRODUCING CARDIOMYOCYTE SHEET
#262MAKING AND USING CARDIOPOIETIC CELLS
#263Polarised Three-Dimensional Cellular Aggregates
#264MACROMOLECULAR CLUSTERS OF CARDIAC STEM CELLS AND METHODS FOR MAKING AND USING THEM
#265Method of processing collagen-based tissue for bioprosthetic devices
#266Method For Isolating A Cardiomyocyte Population
#267DIFFERENTIATION OF PLURIPOTENT STEM CELLS AND CARDIAC PROGENITOR CELLS INTO STRIATED CARDIOMYOCYTE FIBERS USING LAMININS LN-511, LN-521 AND LN-221
#268CELLS DIFFERENTIATED FROM IMMUNOENGINEERED PLURIPOTENT CELLS
#269ON-CHIP PACEMAKER CELLS FOR ESTABLISHING AN AUTONOMOUSLY CONTROLLABLE ELECTRICAL PACEMAKER
#270Muscle cell patches and uses therefor
#271NON-IMMUNOGENIC ENGINEERED TISSUE AND METHODS OF PRODUCING AND USING THE SAME
#272MITOCHONDRIAL TRANSPLANTATION TO ALTER ENERGY METABOLISM
#273TRANSCRIPTION FACTOR-BASED GENERATION OF PACEMAKER CELLS AND METHODS OF USING SAME
#274CARDIAC NEURAL CREST CELLS AND METHODS OF USE THEREOF
#275Biomaterials for 3D Cell Growth and Differentiation
#276REPROGRAMMING OF CELLS TO A NEW FATE
#277Enhanced cardiomyocyte regeneration
#278Electrical stimulation of cells to induce enhanced secretome for therapeutic applications
#279CARDIAC REPAIR BY REPROGRAMMING OF ADULT CARDIAC FIBROBLASTS INTO CARDIOMYOCYTES
#280IN VITRO METHOD FOR PROVIDING STEM CELL DERIVED CARDIOMYOCYTES
#281Method for expanding stemness and differentiation potential of pluripotent cells
#282Modeling neurological disorders and ataxias with cardiac dysfunction using bioengineered heart tissues
#283MEDIUM FOR INDUCING DIFFERENTIATION OF STEM CELLS INTO MESODERMAL CELLS AND METHOD FOR PRODUCING MESODERMAL CELLS
#284Ultrathin interfacial layer on a hydrogel to direct its surface properties and cell adhesion
#285Reversible stencils for fabricating micro-tissues
#286Metamaterial scaffolds and uses thereof
#287Promotion of cardiomyocyte proliferation and regenerative treatment of the heart by inhibition of microRNA-128
#288CARDIOSPHERE-DERIVED CELLS AND THEIR EXTRACELLULAR VESICLES FOR TREATMENT AND PREVENTION OF CANCER
#289TISSUE-SPECIFIC DIFFERENTIATION MATRICES AND USES THEREOF
#290ABNORMAL CARDIAC RHYTHM MYOCARDIAL MODEL AND METHOD FOR PRODUCING SAME, AGENT FOR FORMING ABNORMAL CARDIAC RHYTHM MYOCARDIAL MODEL, AND METHOD FOR EVALUATING DRUG EFFICACY OF HEART DISEASE THERAPEUTIC
#291METHODS AND COMPOSITIONS FOR GENERATING EPICARDIUM CELLS
#292CELL PRODUCTION METHOD
#293CPC EXOSOMES MIRNA373 COMBINATION THERAPIES
#294Cardiosphere-derived cell sheet and methods of making and using the same
#295ACTIVATION-INDUCED TISSUE-EFFECTOR CELLS SUITABLE FOR CELL THERAPY AND EXTRACELLUAR VESICLES DERIVED THEREFROM
#296Compositions and methods for cellular reprogramming
#297PROCESS FOR PRODUCING CARDIAC ORGANOIDS
#298Methods for selective inhibition of pluripotent stem cells
#299Cardiomyocyte preparation and preparation method therefor and use thereof
#300Cardiomyocyte maturation promoter